The document discusses recent Vietnamese laws and regulations regarding the pharmaceutical industry and their impact on foreign invested enterprises (FIEs). Key points include: 1. FIEs can manufacture drugs domestically through new enterprises, joint ventures, or contracts but domestic products are prioritized in government tenders. 2. FIEs can import drugs but are restricted to selling only to wholesalers. Wholesalers must be able to distribute products without FIE involvement. 3. The new decree prohibits various distribution activities by FIEs like selling directly to retailers. FIEs with past licenses for restricted activities will need to change their business objectives.